Operating

Impairment of Goodwill and Other Intangibles

Amgen Impairment of Goodwill and Other Intangibles decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $800.00M to $0.00. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ1 2023
Last reportedQ1 2026Apr 30, 2026

How to read this metric

High impairment charges signal poor historical capital allocation or a decline in the value of acquired business units.

Detailed definition

This captures non-cash charges taken when the carrying value of goodwill or intangible assets exceeds their fair market...

Peer comparison

Peer companies with frequent M&A activity will show similar, though infrequent, impairment events.

Metric ID: pm_goodwill_and_intangible_impairment

Historical Data

11 periods
 Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q3 '25Q1 '26
Value$212.75M$212.75M$212.75M$212.75M$68.00M$0.00$61.00M$30.00M$800.00M$400.00M$0.00
QoQ Change+0.0%+0.0%+0.0%-68.0%-100.0%-50.8%>999%-50.0%-100.0%
YoY Change-68.0%-100.0%-71.3%-85.9%>999%+555.7%-100.0%
Range$0.00$800.00M
CAGR-100.0%
Avg YoY Growth+172.4%
Median YoY Growth-71.3%
Current Streak2 quarters decline

Frequently Asked Questions

What is Amgen's impairment of goodwill and other intangibles?
Amgen (AMGN) reported impairment of goodwill and other intangibles of $0.00 in Q1 2026.
How has Amgen's impairment of goodwill and other intangibles changed year-over-year?
Amgen's impairment of goodwill and other intangibles decreased by 100.0% year-over-year, from $800.00M to $0.00.
What does impairment of goodwill and other intangibles mean?
A non-cash write-down of the value of previously acquired assets or brands.